Alteri Wealth LLC Takes $374,000 Position in Colgate-Palmolive (NYSE:CL)

Alteri Wealth LLC bought a new stake in Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,112 shares of the company's stock, valued at approximately $374,000.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Axxcess Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 0.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock valued at $3,526,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Financial Services LLC raised its holdings in shares of Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after acquiring an additional 118 shares during the period. Wescott Financial Advisory Group LLC boosted its position in shares of Colgate-Palmolive by 3.5% during the 4th quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock valued at $320,000 after acquiring an additional 119 shares during the last quarter. D Orazio & Associates Inc. grew its holdings in shares of Colgate-Palmolive by 4.2% in the fourth quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock valued at $271,000 after purchasing an additional 120 shares during the period. Finally, Lantz Financial LLC increased its position in Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after purchasing an additional 122 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.3 %

NYSE:CL traded up $0.30 during trading hours on Tuesday, hitting $91.04. The company's stock had a trading volume of 3,605,207 shares, compared to its average volume of 4,641,013. The stock has a market capitalization of $73.78 billion, a P/E ratio of 25.86, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a fifty day moving average of $92.28 and a 200-day moving average of $91.71. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm's revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive declared that its Board of Directors has initiated a stock repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.28%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Wells Fargo & Company raised their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Tuesday, April 29th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Raymond James reissued an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, Piper Sandler lowered their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $102.39.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.